The fifth annual CanTech Investment Conference was held on Wednesday (January 31) at the Metro Toronto Convention Centre and–if one thing’s for certain–interest in the tech sector is alive now more than ever in Canada.
This year’s conference was slightly different than previous ones: for the first time in its history, the conference was sold out, and the show floor had grown by at least 50 percent due to an increase in demand.
If you weren’t able to attend, the Investing News Network (INN) was there busy covering some floor talks and panels, company presentations, interviewing and–of course–tweeting throughout the day. Stay tuned for our video interview coverage from the event in the coming week or so.
The conference began with the TSX opening on the show’s main floor.
Massive TSX opening at #CantechConf pic.twitter.com/LyvundrfiR
— Richard Southern (@richard680news) January 31, 2018
From there, panel discussions got underway, including one about cryptocurrency mining–which, unsurprisingly, attracted a large audience. The panel was moderated by Daniel Kim from Paradigm Capital while speakers included Aydin Kilic from Fortress Blockchain, James Goodwin from Great North Data, and Patrick Gray CEO of HashChain Technology (TSXV:KASH).
Jam packed crypto mining panel to start #cantechconf this year! pic.twitter.com/h2NR7Y2PJI
— Cambridge House (@Cambridge) January 31, 2018
At #CantechConf and the #blockchain mining panel is this oversubscribed ! #needabiggerroom @paradigmcap pic.twitter.com/CHhdj5UHEL
— cgtheoret (@cgtheoret) January 31, 2018
Lined up beyond the walls for the #cantechconf Paradigm Innovation Stage for #cryptomining and #blockchain@datametrex @RoninBlockchain @nexalogy #BellLetsTalk pic.twitter.com/MLHnAxyQwD
— Jeff Stevens (@123marley123) January 31, 2018
INN then stopped by the company presentation of DMG Blockchain, a privately-held company based out of Vancouver. The company is a full-service blockchain and cryptocurrency company with a focus on becoming a bitcoin mining host leader.
It’s a packed house for @dmgblockchain presentation at #CantechConf pic.twitter.com/6AK8f0WNB9
— Tech Investing News (@INN_Technology) January 31, 2018
In general, cryptocurrencies and blockchain were the biggest highlight reels of the day, but a cannabis discussion panel on Canada’s role as a global leader in the industry also attracted a large audience.
Cannabis panel is underway at the #CantechConf to discuss if Canada can maintain its leadership role in the space pic.twitter.com/Dois3PALXl
— Tech Investing News (@INN_Technology) January 31, 2018
The panel included Russell Stanley from Echelon Wealth Partners as the moderator, while the discussion includedMark Zekulin, president of Canopy Growth (TSX:WEED), Chris Wagner, CEO of Emerald Health Therapeutics (TSXV:EMH) and Greg Engel, CEO of Organigram (TSXV:OGI).
Can Canada keep its lead in Cannabis in the world? @CanopyGrowth @discoverOGI @EmeraldHealthHQ #CantechConf pic.twitter.com/nFn6L5BGuw
— Hanna Zaidi (@HannaFZaidi) January 31, 2018
Panel says the world has been watching Canada’s medical framework as it relates to cannabis, once legalisation is finalised the framework for recreational use in Canada will also be looked at from a global scale #CantechConf
— Tech Investing News (@INN_Technology) January 31, 2018
At #CantechConf @EmeraldHealthHQ‘s Chris Wagner asks “How can we bring something that is unique and different? The Germans are going to figure out how to grow #Cannabis.”
— Michael Hainsworth (@hainsworthtv) January 31, 2018
Discussing Canada’s leadership status in the world of #cannabis in the years ahead with @AmpleOrganics @EmeraldHealthHQ @CanopyGrowth & @discoverOGI #CantechConf pic.twitter.com/TTi5ofQebO
— Erik Dohnberg (@edohnberg) January 31, 2018
Panel discussions and company presentations weren’t the only things keeping attendees and investors interested at the conference. A virtual reality (VR) village was also set up where people could take a break and have some fun with this technology first-hand.
Taking a break from the office to have fun at the VR Village at #CantechConf #Cantech18 #VR #Technology pic.twitter.com/zjQ2ZsPLeF
— Cambridge House (@Cambridge) January 31, 2018
Back to panel discussions, Michael Hainsworth, business reporter with Business News Network hosted “Fireside Chat” with Anthony Di Iorio, CEO and Founder of Decentral and Jaxx, Co-founder of Ethereum., Decentral & Jaxx to discuss the future of blockchain technologies. Stay tuned for INN’s exclusive video interview with Di Iorio in the coming weeks.
Anthony Di Iorio on the future of blockchain at #CantechConf pic.twitter.com/Z0TDuN5qqq
— MrBrentLessard (@MrBrentLessard) January 31, 2018
As you can tell, blockchain, cryptocurrencies and cannabis were the biggest draws at the CanTech Investment Conference this year, and it’s not hard to see why: with recreational legalization of cannabis slated for this year in Canada and the country becoming a hot spot for blockchain technologies, there’s certainly plenty of investor interest in these two sectors.
On that note, another panel discussion moderated by Michael Hainsworth from BNN called Blockchain: Hype or Hope? included commentary from Di Iorio, Frank Holmes, who is chief investment officer at US Global Investors, and Kevin Rooke from Coinsquare. Over the next coming week or so INN will post its exclusive interview with Holmes, which includes his thoughts on the gold and bitcoin debate.
One key takeaway from the panel included the importance of differentiating between what is a real blockchain company and what’s not–and to particularly to be cautious of companies that suddenly change their name to include blockchain in its title.
Discussion panel underway to discuss #blockchain and #bitcoin and how to differentiate the difference between a real blockchain company and what’s not #CantechConf pic.twitter.com/c1dziwPcl8
— Tech Investing News (@INN_Technology) January 31, 2018
Checking out #CantechConf and some panel predictions about where the blockchain industry is heading pic.twitter.com/JtiahwrSCK
— Paul Horbal (@horbal) January 31, 2018
While there’s certainly plenty of hype and speculation surrounding the industry, Di Iorio said he feels hopeful about the industry’s future.
Di Iorio says while there’s a lot of hype surrounding #crypto and #blockchain there is more hope in the industry moving forward #CantechConf
— Tech Investing News (@INN_Technology) January 31, 2018
The discussion panel was arguably the most attended of the day with standing-room only.
Standing room only in the #Blockchain: Hype or Hope? At #CantechConf pic.twitter.com/4PcJbwP9Ka
— Cambridge House (@Cambridge) January 31, 2018
Other highlights of the day included Vanbex Futures: Investing in the Future of Blockchain with Kevin Hobbs, CEO of Vanbex Futures leading the discussion. Stay tuned in the coming days and weeks for our one-on-one interview with Hobbs about the future outlook for blockchain. Cantech Letter, Canadian tech of the year with a judge’s panel where each judge presented three choices, one of which they had invested in.
While the CanTech Investment Conference is done for another year, it was certainly one for the books. After a busy-filled day, INN can’t wait to share additional insight from the show, including its video interviews with a number of experts and companies within the industries.
Don’t forget to follow us @INN_Technology for real-time news updates!
Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: HashChain Technology is a client of the Investing News Network. This article is not paid for content.
An Emerging Markets Sponsored Commentary
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
<p align="justify"> For those of you new to this compelling consumer packaged goods and cannabis opportunity, stick around. </p>
<p> In a press release titled “ <em> <a href="https://investingnews.com/company-profiles/bevcanna-cse-bev-cannabis-infused-beverages-canada/">BevCanna</a> Provides Outlook on Strategic Evolution to Global Health and Wellness Company </em> ” the Company laid out some pretty strong guidance as to their goals and objectives in the very near future. To sum it up, the Company plans to rapidly accelerate the introduction of new products in the marketplace. </p>
<p> The Company does a thorough job laying out the four growth verticals. Let’s take a look: </p>
<p> <strong> 1) </strong> <strong> <a href="https://investingnews.com/company-profiles/bevcanna-cse-bev-cannabis-infused-beverages-canada/">BevCanna</a> Canada </strong> – On the heels of receiving a coveted Health Canada Standard Processing License (SPL) to manufacture and sell cannabis beverages and products in the Canadian market the Company can now start production on its Keef beverages and white labels in major Canadian markets. Partner this with a a commercial roll-out strategy and new B2B relationships with other license holders and non-license holders in the Canadian market and there is significant growth opportunity to be had. </p>
<p> <strong> 2) </strong> <strong> Naturo Group </strong> – This is a recent <a href="https://investingnews.com/company-profiles/bevcanna-cse-bev-cannabis-infused-beverages-canada/">BevCanna</a> acquisition of Naturo Group which could really accelerate the Company’s entry into the growing health and wellness industry. The deal gives them a 40,000 sq. ft. manufacturing facility, alkaline spring water aquifer, 315-acres of land, and more. All this could really expedite monetization of their leading plant-based beverage and nutraceutical brand, TRACE. </p>
<p> <strong> 3) </strong> <strong> Pure Therapy </strong> – This is the big American+ play for the Company via the recently acquired U.S. & international hemp & nutraceutical Pure Therapy e-commerce platform which sells a range of natural health products, including nutraceutical and hemp-based cannabidiol products throughout North America and Western Europe. It’s significant because of the size of both of those marketplaces which if exploited would be revenue accretive to the Company’s firm foothold in Canada. It’s worth mentioning that the Company now owns a proven e-commerce platform through which they can sell ALL their legally permitted products. Remember when Wal-Mart bought start-up online retailer Jet.com just to get a jumpstart on e-commerce? <a href="https://www.globenewswire.com/Tracker?data=0-TQSQ8tsqvMs3HYTHFi9YRxecAlNzssB1eUpM7cx7kY1OUsy9RgnUOpuLPTUGNpt1_OHdg5L3iC-AbbGhg_GW7T0y4Go-H8yYQlW_hEAhcGahrZoEEytxCDWNJtVrqFDEupIjcpxrCWqBBvZE8IqNgV2Ikh92erR7f0WnGInuY=" rel="nofollow noopener noreferrer" target="_blank"> Read this article </a> and ask yourself what’s in common. </p>
<p> <strong> 4) </strong> Not only does the Company have a significant foothold and barrier to entry in the Canadian cannabis sector, as well as U.S. health and wellness e-commerce sector; But the Company seeks to pursue rapid U.S. cannabis growth vis-à-vis an exclusive partnership with award-winning, #1 U.S. cannabis infused beverage company, Keef. <a href="https://investingnews.com/company-profiles/bevcanna-cse-bev-cannabis-infused-beverages-canada/">BevCanna</a> will have access to Keef’s extensive U.S. manufacturing and distribution network of over 1,000 dispensaries and delivery services across Colorado, California, Arizona, Nevada, Michigan, Oklahoma, and Puerto Rico. </p>
<p> It’s a lot. Even our pithy distillation herein is a word or hundred longer than the Internet’s general attention span. But smart money reads the details, looks at trajectories and potential, weighs the risk and reward. </p>
<p> And if you’re as obsessed with significant assets and established revenue streams as an indicator of success and valuation, and a rapid expansion of the company’s portfolio of products elegantly across a multi-channel sales and distribution network, <a href="https://investingnews.com/company-profiles/bevcanna-cse-bev-cannabis-infused-beverages-canada/">BevCanna</a>’s recent news should be of interest. </p>
<p> <strong> About The Emerging Markets Report: </strong> </p>
<p align="justify"> <em> The Emerging Markets Report </em> is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. </p>
<p> For more informative reports such as this, please sign up at <a href="https://www.globenewswire.com/Tracker?data=24v7ri5u1IgBrCzNnF-gce6FOnAdZQN7es-dhKqi2-WdLkbQ2yerdtQs_rBPl84bpr2Qv205OtwjtyAIy_eS28lGVohmaceCYDa6jtUFSKYdtcEE3X_m5UWIry2n3q9bsDNIqrq-GDu8fuUf5gHn1iT8P7eY1z3xF6eL-ric7vw=" rel="nofollow noopener noreferrer" target="_blank"> http://www.emergingmarketsllc.com/newsletter.php </a> </p>
<p> <strong> Must Read OTC Markets/SEC policy on stock promotion and investor protection </strong> </p>
<ul type="disc"><li> <a href="https://www.otcmarkets.com/learn/policy-on-stock-promotion" rel="nofollow noopener noreferrer" target="_blank"> https://www.otcmarkets.com/learn/policy-on-stock-promotion </a> </li>
<li> <a href="https://www.otcmarkets.com/learn/investor-protection" rel="nofollow noopener noreferrer" target="_blank"> https://www.otcmarkets.com/learn/investor-protection </a> </li>
<li> <a href="https://www.sec.gov/news/press-release/2017-79" rel="nofollow noopener noreferrer" target="_blank"> https://www.sec.gov/news/press-release/2017-79 </a> </li>
<li> <a href="https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html" rel="nofollow noopener noreferrer" target="_blank"> https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html </a> </li>
</ul><p> Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. </p>
<p> We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. </p>
<p> EMC has been paid $350,000 by <a href="https://investingnews.com/company-profiles/bevcanna-cse-bev-cannabis-infused-beverages-canada/">BevCanna Enterprises</a> Inc. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. <a href="https://www.globenewswire.com/Tracker?data=24v7ri5u1IgBrCzNnF-gcbvQ9LrZ5kyMSLYfrb7OYWJ5tCAIV6yexylbVA194HZsGb6J_Zlg7N5QiYtkv6KGdbBA3IolmhNNjHOOAJJHhOkGSrVbYhfheSUC2OETVu4CgKoQMZHakYSdSJlpbKZB1G7MieyUXINSABQQzgQtcw4=" rel="nofollow noopener noreferrer" target="_blank"> http://emergingmarketsllc.com/disclaimer.php </a> </p>
<p> <strong> Emerging Markets Consulting, LLC <br/></strong> Florida Office <br/> 390 North Orange Ave Suite 2300 <br/> Orlando Fl, 32801 <br/> E-mail: <a href="https://www.globenewswire.com/Tracker?data=1QYec2jryhFsuMrl7B4DepXa2qVVbxt3ddm8E9Hs50f8vQN0UzCE2XJ59XKc4Cgvd3St6VvbnoIhp2wPSJn5PtltlTcCPhi4kmKmRiik3eaYHxJez1HrmBjuSgOrHB1yn0RGNjs4Twl4Zb6LLas0QQ==" rel="nofollow noopener noreferrer" target="_blank"> jamespainter@emergingmarketsllc.com </a> <a href="https://www.globenewswire.com/Tracker?data=-t0My-R3vjoBoe-VgE9JYBJqK6_J82N-o0I2K6s3UX7t0RTKFNEw_JTcxMeYclYhCybmxwv9Tz5sGiDtUTxIoziZe1-84tQimONeSWR3byQ=" rel="nofollow noopener noreferrer" target="_blank"> <br/></a> Web: <a href="https://www.globenewswire.com/Tracker?data=U4pPqmf7rx1GoirojGWSieAUKazJyW2RIkVqZuFrUIXXfwlW8AtXzyBmPUew95AGCfNXbZ4Cr04grkM48YaVpb4mlOB59fRoAwUxvKq_PBJhpXCMthXyUGVtxU2VCZ_U" rel="nofollow noopener noreferrer" target="_blank"> www.emergingmarketsllc.com </a> </p>
<p></p>
<p> <img class="lazy" data-src="https://www.globenewswire.com/newsroom/ti?nf=ODE4NDk5MiM0MDQ5ODc5IzUwMDA3ODA1MQ==" data-srcset="" height="1" src="https://www.globenewswire.com/newsroom/ti?nf=ODE4NDk5MiM0MDQ5ODc5IzUwMDA3ODA1MQ==" srcset="" width="1"/><br/><img class="lazy" data-src="https://ml.globenewswire.com/release/track/f6d7c0b3-0cf2-44fb-a154-056b508f0904" data-srcset="" height="1" referrerpolicy="no-referrer-when-downgrade" src="https://ml.globenewswire.com/release/track/f6d7c0b3-0cf2-44fb-a154-056b508f0904" srcset="" width="1"/></p>
<p> <a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/aa0a5fcd-da69-4eeb-8bef-43c69c36d8c8" rel="noopener noreferrer" target="_blank"> <img alt="Primary Logo" border="0" class="lazy" data-src="https://ml.globenewswire.com/media/aa0a5fcd-da69-4eeb-8bef-43c69c36d8c8/small/emc-logo-gnw-jpg.jpg" data-srcset="" height="135" src="https://ml.globenewswire.com/media/aa0a5fcd-da69-4eeb-8bef-43c69c36d8c8/small/emc-logo-gnw-jpg.jpg" srcset="" width="150"/></a> </p>
</div>
<p>News Provided by GlobeNewswire via QuoteMedia</p>
<p></p><div class="stock-information sidebar-block">
<div class="title">Request an Investor Kit: <h3>BevCanna</h3></div>
<form action="https://investingnews.com" id="subscribe_per_category" method="POST">
<div class="form-column left">
<input name="profiles_only" type="hidden" value="yes"/><input name="subscription_form" type="hidden" value="yes"/><input name="subscribe_company_profile_form" type="hidden" value="1"/><input name="source" type="hidden" value="https://investingnews.com/news/cannabis-investing/emerging-markets-report:-expand-the-brand/"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="form_name" type="hidden" value="subscribe_cprofile_use_posts"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="cprofiles[]" type="hidden" value="Tzo4OiJzdGRDbGFzcyI6NDp7czoyOiJpZCI7czozNjoiYjcyMTEwNjEtYzZjMC03OWM1LTA5MTQtNWNkZGQ3Y2FkMjVkIjtzOjQ6Im5hbWUiO3M6ODoiQmV2Q2FubmEiO3M6NDoid3BpZCI7czo5OiIxMDE1MDI3MDIiO3M6MzoidXJsIjtzOjA6IiI7fQ=="/><input class="form-control" id="FirstName" name="first_name" placeholder="First Name" required="" type="text" value=""/><input class="form-control" id="LastName" name="last_name" placeholder="Last Name" required="" type="text" value=""/><input class="form-control" id="email" name="email" placeholder="Email" required="" type="email" value=""/><input class="form-control" id="phone" name="user_phone" pattern="[\+\s0-9]{3,15}" placeholder="Phone" title="Telephone number. Only digits and space signs are allowed" type="tel" value=""/></div>
<div class="form-column right">
<div class="extra-input">
<input id="AccreditedInvestor" name="accredited_investor" type="checkbox"/><label class="checkbox-label" for="AccreditedInvestor">
Include me in the <b>Accredited Investor</b> email list
<span class="help">
<i aria-hidden="true" class="fa fa-question-circle"></i>
<div class="help-box bigger">
Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above.
</div>
</span>
</label>
</div>
<div class="more">
<input class="btn btn-primary" type="submit" value="Get More information"/></div>
<p class="legend">By completing this form, you are giving consent to receive communication from BevCanna using the contact information you provide. And remember you can unsubscribe at any time.</p>
</div>
</form>
</div>
Keep reading...
Show less
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
<p>With a recently renewed financial boost and two significant deals among major players in the country, M&A looks set to bring in a new order for Canadian cannabis.</p>
<div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
<p>Meanwhile, as Canadian companies wait for policy changes below the border, M&A may help them position ahead of changes in the American legal landscape.</p>
<h2>Recent deals push consolidation trend for Canadian M&A</h2>
<p>Heading into 2020, a <a href="https://investingnews.com/daily/cannabis-investing/cannabis-outlook-2020/">pattern of consolidation</a> was expected for Canadian cannabis operators. However, complications from the financial uncertainty caused by the COVID-19 pandemic likely affected plans.</p>
<p>The latter half of 2020 and the start of 2021 brought some newfound momentum for cannabis investments; this came alongside serious developments in the Canadian marketplace that boosted the performance of operators, according to Nawan Butt, portfolio manager with Purpose Investments.</p>
<p>The tone for M&A between cannabis producers in Canada was set late last year, when Aphria (NASDAQ:<a href="https://investingnews.com/stock-information/?symbol=APHA:US">APHA</a>,TSX:APHA) and Tilray (NASDAQ:<a href="https://investingnews.com/stock-information/?symbol=TLRY:US">TLRY</a>) announced a <a href="https://investingnews.com/daily/cannabis-investing/cannabis-weekly-aphria-tilray-tie-knot/">company union</a> to investors.</p>
<p>The deal sent waves across the cannabis investing landscape as it combined two of the biggest names in the public markets, resulting in a company worth approximately C$5 billion.</p>
<p>Butt told the Investing News Network (INN) that the Aphria and Tilray deal was a great opportunity for each company to fill the other’s weak spots. “A great merger of equals, I would say,” he said.</p>
<p>Following confirmation of the transaction, Som Seif, founder and CEO of Purpose Financial, <a href="https://investingnews.com/daily/cannabis-investing/experts-cannabis-industry-needs-aphria-tilray-deal/">said the deal</a> was a starting point for more consolidation in the Canadian cannabis space.</p>
<p>And the trend did in fact continue thanks to an all-share <a href="https://investingnews.com/daily/cannabis-investing/cannabis-weekly-hexo-strikes-acquisition-deal-for-zenabis/">C$235 million acquisition deal</a> struck between HEXO (NYSE:<a href="https://investingnews.com/stock-information/?symbol=HEXO:US">HEXO</a>,TSX:HEXO) and fellow public producer Zenabis Global (TSX:<a href="https://investingnews.com/stock-information/?symbol=ZENA:CA">ZENA</a>).</p>
<p>“Canadian licensed producers (LPs) have been given a second lifeline of sorts here where the capital markets are back to support them and their balance sheets and put them back into growth mode,” Butt told INN.</p>
<h2>What are Canadian companies looking for in M&A right now?</h2>
<p>Narbe Alexandrian, CEO of RIV Capital (TSX:<a href="https://investingnews.com/stock-information/?symbol=RIV:CA">RIV</a>,OTC Pink:CNPOF), formerly known as Canopy Rivers, told INN that just over two years after federal cannabis legalization in Canada there has been a critical evolution in terms of how deals are valued.</p>
<div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
<p>“At the time, when legalization was taking shape, it was always a race towards who had the most supply,” he said. “Fast forward to now, we’ve noticed that it’s not about who has the infrastructure, it’s about who has the eyeballs, who has the demand, who can capture that demand.”</p>
<p>The executive explained that this shift in how the market approaches valuation has led to a renaissance in Canadian cannabis by way of a multitude of companies seeking a reset button of sorts.</p>
<p>“That reset button could be bankruptcy, or it could be a fire sale of the asset,” he said.</p>
<p>The bigger names in the space have also faced difficulties in a changing financial landscape, and Alexandrian said that for the most part they will likely stop trying to do everything. As a result, he explained, there will be a need for other cannabis companies to fill the gaps left open.</p>
<p>The Valens Company (TSXV:<a href="https://investingnews.com/stock-information/?symbol=VLNS:CA">VLNS</a>,OTCQX:VLNCF) President Jeff Fallows agreed with Alexandrian. In a conversation with INN, the executive said M&A strategy has been directly impacted by a shift in the style of executive leadership at the top of the Canadian cannabis space.</p>
<p>“You’re seeing more and more jettisoning of things that are not core (to the big producers), and Valens has been a particular benefactor of that,” he said. Valens specializes in extraction services and has even moved forward with its own line of products, such as vape pens.</p>
<p>Fallows explained that in meetings with newer management teams at LPs, he hears them ask, ‘Why am I doing vape pens?’ and instead they elect to pursue a partnership.</p>
<p>“(It’s) very good from the Valens perspective, but I think (it is) symbolic of the growing up and the evolving of the cannabis sector as a CPG sector,” Fallows said.</p>
<p>Butt has argued that the Canadian market will reach a point where a controlling top of leading companies holds a dominant majority position in the domestic market.</p>
<p>While the green rush of cannabis investment initially led to an explosion of companies and investment avenues, the expert thinks it’s most likely the market will end up with a reduced number of operators.</p>
<p>“What I anticipate for us to start seeing more often is more mergers between tier one and tier two players,” Butt said, classifying the types of Canadian cannabis companies out there.</p>
<div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
<p>He warned that none of the future deals that may come into play will be focused on infrastructure or capacity options.</p>
<p>“Nobody wants to buy capacity right now,” said Butt. “What is worth value is brands, relationships, innovative product formats and international exposures.”</p>
<h2>Canadians pine for US entry points</h2>
<p>One aspect all experts can agree on is the way the US marketplace has affected the path of expansion for Canadian companies.</p>
<p>Canadian firms have entered the US market through strategic investments or expansions with CBD derivative options, which are legally permitted thanks to hemp-derived CBD permissions in the country.</p>
<p>“We anticipate there will be further mergers of sorts going into this year, especially in anticipation of the US opportunity opening up for Canadian LPs,” Butt told INN.</p>
<p>Those business opportunities, however, do not represent medical or recreational cannabis product sales in the fractured state markets. That avenue has been entirely dominated by US-based multi-state operators (MSOs).</p>
<p>“US cannabis companies are now hitting a level of maturity where real business models are emerging,” Joe Bayern, CEO of Curaleaf Holdings (CSE:<a href="https://investingnews.com/stock-information/?symbol=CURA:CNX">CURA</a>,OTCQX:CURLF), told S&P Global Market Intelligence.</p>
<p>The growth cycle afforded by the value size available from US cannabis businesses has shifted the attention of Canadian companies with enough financial options to pursue a run below the border.</p>
<p>“Investors are speculating that Canadian cannabis companies will be able to access that market in the near future,” Butt said.</p>
<p>While the desire is present, and the Canadians are <a href="https://www.bnnbloomberg.ca/we-ve-got-to-be-in-the-u-s-aphria-ceo-looks-south-amid-strong-q2-results-1.1548476">starting to talk more openly</a> about their intentions with the US market, the legal framework makes things murky in terms of the approach possible.</p>
<p>“We believe that the Canadian LPs and the potential positioning of entry into the US market is too early,” Charles Taerk, president and CEO of Faircourt Asset Management, commented to INN. “And so all of this structuring, raising capital and the craze in the Canadian LPs, market prices, raising more than the MSOs — (it) doesn’t make a lot of sense to us.”</p>
<p>Taerk explained that from his view cannabis policy in the US has moved at a glacial pace in the past, and that will not change despite the country’s new Democratic political leadership.</p>
<div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
<p>“There is great exuberance with respect to the Democrats controlling the Senate,” he said. But according to the financial executive, the current administration has bigger fish to fry right now in terms of policy.</p>
<p>“We believe that there is going to be some type of legislation and it will be tabled. But we don’t think that federal legalization is in the cards, at least this year,” Taerk said.</p>
<p>Dan Ahrens, chief operating officer and portfolio manager at AdvisorShares, told INN the Canadian companies find themselves in a tricky position regarding the US growth opportunity.</p>
<p>“I think that’s one of the most interesting stories still, that disconnect between Canada and the US. For the cannabis operators in Canada, they have no choice but to speak about entry into the US,” he said.</p>
<p>Ahrens told INN Canadian cannabis companies will try everything possible to secure a stake in the US marketplace; some even already have viable access points ready in the case of future policy changes.</p>
<p>“The US operators are going to look extremely tantalizing to Canadian firms, to other US firms and to other US or worldwide CPG companies,” said Ahrens, who manages the AdvisorShares Pure Cannabis ETF (ARCA:<a href="https://investingnews.com/stock-information/?symbol=YOLO:US">YOLO</a>) and the recently launched AdvisorShares Pure US Cannabis ETF (ARCA:<a href="https://investingnews.com/stock-information/?symbol=MSOS:US">MSOS</a>).</p>
<p>Despite the potential associated with the US marketplace, one financial advisor expressed concern at the current timeline of events starting to surround Canadian companies in relation to US entries.</p>
<p>Ahrens explained that Canadian companies have continued to see trading activity related to US-based developments. “They trade up improperly, I guess is a good way to say it, based on news in the US,” he said. “But it won’t last.”</p>
<h2>Investor takeaway</h2>
<p>The future seems uncertain for Canadian cannabis companies, especially in relation to the US marketplace — it remains unclear how the country’s cannabis players will capitalize on the attractive American market. For now, what’s evident is that interest in this potential market will surely drive the possibility of critical cross-border M&A plans.</p>
<p><em>Don’t forget to follow us <a href="https://twitter.com/inn_cannabis">@INN_Cannabis</a> for real-time updates!</em></p>
<p><strong>Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.</strong></p>
<p><strong>Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.</strong></p>
<div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
March 04 | 2021
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
<p>The polyphenols in olives have demonstrated the ability (Alagna et al. BMC Plant Biology 2012, 12:162) to protect LDL particles from oxidative damage and to maintain normal blood HDL-cholesterol concentrations, required to maintain normal hemostatic function. These polyphenols have also demonstrated positive effects on learning and reducing memory deficits found in ageing (such as those related to the overproduction of amyloid-beta peptide). In addition, they can impact gut microbial balance by promoting growth of bacteria, influencing lipid metabolism and inhibition of pathogenic bacteria, as well as increase bone density.</p>
<p>BioHarvest’s olive cells-based product will contain verbascoside, which is an ingredient with potent activity from the olive tree. This is a major differentiator of our product as most olive extracts are based only on hydroxytyrosol, typical of the inedible vegetation waters from the tree and of aged extra-virgin olive oils. </p>
<p> “<i>We are very proud to have achieved this milestone</i>,” said Dr. Yochi Hagay, CTO of the Company and added, <i>“Our Nutraceuticals development program includes new products with active ingredients that have scientifically demonstrated a positive impact on a person’s wellbeing. Our olive-based Nutraceutical contains a matrix of active components with special antioxidant activities and unlike other products (which use the typical solvent extraction technique), is based on our proprietary BioFarming technology which keeps the original natural molecular conformation of the components and hence delivers optimal bioavailability.” </i></p>
<p> “<i>This is yet one more achievement from our talented scientists. It provides further evidence of the vast potential of our BioFarming technology which can produce compounds in their natural structure and maximize the health of consumers. We expect to commercialize this olive based product alongside our current flagship VINIA® product in 2022 to create a portfolio of superfruits and Nutraceuticals with unprecedented benefits and sales growth potential in the $53 Billion dietary supplement market in the US (2020 Persistence Market Research),” </i>said Ilan Sobel, the CEO of the Company.</p>
<p><b>About <a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a></b></p>
<p>Based in Vancouver BC, <a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a> is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology. It is the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself. The Company’s technology is non-GMO and has already been validated by VINIA®, the red grapes cells functional food/dietary supplement produced and sold by <a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a> The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA® and other Super Fruit Nutraceutical products. Further, by adapting this technology to the cannabis plant, and building adequate production capacity, <a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a>‘s objective is to also become a leading supplier of cannabis for both medicinal and legal recreational purposes.</p>
<p>For more information visit: <a href="https://www.newsfilecorp.com/redirect/QGVOF83LG" rel="noopener noreferrer" target="_blank">www.bioharvest.com</a>.</p>
<p><b><a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a></b><br/>Ilan Sobel, Chief Executive Officer</p>
<p><b>For further information, please contact:</b><br/>Dave Ryan, VP Investor Relations & Director<br/>Phone: 1 (604) 622-1186<br/>Email: <a href="mailto:dave@bioharvest.com" rel="noopener noreferrer" target="_blank">dave@bioharvest.com</a><u> </u></p>
<p><a href="https://www.newsfilecorp.com/redirect/px2qHw5a4" rel="nofollow noopener noreferrer" target="_blank">Twitter</a><br/><a href="https://www.newsfilecorp.com/redirect/Yv7mhpMWe" rel="nofollow noopener noreferrer" target="_blank">Facebook</a><br/><a href="https://www.newsfilecorp.com/redirect/0z27srkw1" rel="nofollow noopener noreferrer" target="_blank">LinkedIn</a><br/><a href="https://www.newsfilecorp.com/redirect/RXLzCAOWP" rel="nofollow noopener noreferrer" target="_blank">YouTube</a></p>
<p><b>Forward-Looking Statements </b></p>
<p><i>Information set forth in this news release includes might include forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular, there is no assurance that we will achieve our objective of making our products available in multiple markets and exposing our technology to different verticals. Delays and cost overruns may result in delays achieving our objectives obtaining market acceptance and regulatory approvals for geographic expansion is subject to risk and cannot be guaranteed. The success of the Company in its olive-base’s development program is not an assurance that the Company will be able to commence commercial production when anticipated or at all. </i></p>
<p><i>All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. </i></p>
<p><b>Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.</b></p>
<p id="corporateNewsLogoContainer"><img alt="Corporate Logo" class="lazy" data-src="https://orders.newsfilecorp.com/files/6168/76078_1a149d938406e9ee_logo.jpg" data-srcset="" id="corporateNewsLogo" src="https://orders.newsfilecorp.com/files/6168/76078_1a149d938406e9ee_logo.jpg" srcset=""/></p>
<p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://www.newsfilecorp.com/redirect/mZq3uRM5Z" rel="noopener noreferrer" target="_blank">https://www.newsfilecorp.com/release/76078</a></p>
<p><img alt="" class="lazy" data-src="https://www.newsfilecorp.com/newsinfo/76078/310" data-srcset="" src="https://www.newsfilecorp.com/newsinfo/76078/310" srcset=""/></p>
</div>
<p>News Provided by Newsfile via QuoteMedia</p>
<p></p><div class="stock-information sidebar-block">
<div class="title">Request an Investor Kit: <h3>BioHarvest Sciences</h3></div>
<form action="https://investingnews.com" id="subscribe_per_category" method="POST">
<div class="form-column left">
<input name="profiles_only" type="hidden" value="yes"/><input name="subscription_form" type="hidden" value="yes"/><input name="subscribe_company_profile_form" type="hidden" value="1"/><input name="source" type="hidden" value="https://investingnews.com/news/biotech-investing/bioharvest-sciences-inc.unveils-the-unique-polyphenolic-content-of-its-upcoming-olive-based-nutraceutical/"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="form_name" type="hidden" value="subscribe_cprofile_use_posts"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="cprofiles[]" type="hidden" value="Tzo4OiJzdGRDbGFzcyI6NDp7czoyOiJpZCI7czozNjoiYWJhZmU3MTgtNmUzMC1hYTc0LWVhNjctNWQyNzRhNGY2NjQ1IjtzOjQ6Im5hbWUiO3M6MTk6IkJpb0hhcnZlc3QgU2NpZW5jZXMiO3M6NDoid3BpZCI7czo5OiIxMDE1MTUyMTYiO3M6MzoidXJsIjtzOjA6IiI7fQ=="/><input class="form-control" id="FirstName" name="first_name" placeholder="First Name" required="" type="text" value=""/><input class="form-control" id="LastName" name="last_name" placeholder="Last Name" required="" type="text" value=""/><input class="form-control" id="email" name="email" placeholder="Email" required="" type="email" value=""/><input class="form-control" id="phone" name="user_phone" pattern="[\+\s0-9]{3,15}" placeholder="Phone" title="Telephone number. Only digits and space signs are allowed" type="tel" value=""/></div>
<div class="form-column right">
<div class="extra-input">
<input id="AccreditedInvestor" name="accredited_investor" type="checkbox"/><label class="checkbox-label" for="AccreditedInvestor">
Include me in the <b>Accredited Investor</b> email list
<span class="help">
<i aria-hidden="true" class="fa fa-question-circle"></i>
<div class="help-box bigger">
Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above.
</div>
</span>
</label>
</div>
<div class="more">
<input class="btn btn-primary" type="submit" value="Get More information"/></div>
<p class="legend">By completing this form, you are giving consent to receive communication from BioHarvest Sciences using the contact information you provide. And remember you can unsubscribe at any time.</p>
</div>
</form>
</div>
Keep reading...
Show less
Cresco Labs to Report Fourth Quarter and Full Year 2020 Financial Results on March 25th, 2021
March 04 | 2021
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
<p> <b> Event: </b> Cresco Labs Fourth Quarter and Fully Year 2020 Earnings Conference Call <br/><b> Date: </b> Thursday March 25 <sup> th </sup> , 2021 <br/><b> Time: </b> 8:30a.m. EDT <br/><b> Webcast: </b> <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__event.on24.com_wcc_r_3056149_468FE49FCFC5DB54F980873D49216945%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3D4Mr59KexZFmnnGDuLmxG8RTohNAorUiZ0GPO7pchmPI%26m%3D-bxgb0jbVc-MfIqIDZxMgUsdn4q0QMcIqCYPFz46kuQ%26s%3Dk6qzM0W24ZYurmHM2Ik-RrA4mcdkuOQZ8DQVzaALk88%26e%3D&esheet=52390492&newsitemid=20210304005157&lan=en-US&anchor=Link&index=1&md5=4e982c8bb768287c38140f9d300452b5" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> Link </a> <br/><b> Dial-in: </b> 1-855-9796-654 (US), 1-833-2942-546 (CA), 0800-640-6441 (UK), 44-20-3936-2999 (Int’l) <br/><b> Passcode: </b> 885607 </p>
<p> Archived access to the webcast will be available for one year on the Cresco Labs <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Finvestors.crescolabs.com%2Finvestors%2Foverview%2Fdefault.aspx&esheet=52390492&newsitemid=20210304005157&lan=en-US&anchor=investor+relations+website.&index=2&md5=53c83358adb5a1d114e88e27b99a4b32" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> investor relations website. </a> </p>
<p> <b> About Cresco Labs </b> </p>
<p> Cresco Labs is one of the largest vertically integrated, multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted brands including Cresco, Remedi, High Supply, Cresco Reserve, Good News, Wonder Wellness, FloraCal Farms and Mindy’s Chef Led Artisanal Edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.crescolabs.com%2F&esheet=52390492&newsitemid=20210304005157&lan=en-US&anchor=CrescoLabs.com&index=3&md5=11c257fc46499b628499ba57e858705b" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> CrescoLabs.com </a> . </p>
<p> <b> Forward Looking Statements </b> </p>
<p> This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the company’s Annual Information Form dated April 28, 2020, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise. </p>
<p> <img alt="" class="lazy" data-src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20210304005157r1&sid=quot2&distro=nx&lang=en" data-srcset="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20210304005157r1&sid=quot2&distro=nx&lang=en" srcset=""/><span></span> </p>
<p id="mmgallerylink"> <span id="mmgallerylink-phrase"> View source version on businesswire.com: </span> <span id="mmgallerylink-link"> <a href="https://www.businesswire.com/news/home/20210304005157/en/" rel="nofollow noopener noreferrer" target="_blank"> https://www.businesswire.com/news/home/20210304005157/en/ </a> </span> </p>
<p> <i> Media: </i> <br/> Jason Erkes, Cresco Labs <br/> Chief Communications Officer <br/><a href="mailto:press@crescolabs.com" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> press@crescolabs.com </a> </p>
<p> <i> Investors: </i> <br/> Jake Graves, Cresco Labs <br/> Manager, Investor Relations <br/><a href="mailto:investors@crescolabs.com" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> investors@crescolabs.com </a> </p>
<p> <i> For general Cresco Labs inquiries: </i> <br/> 312-929-0993 <br/><a href="mailto:info@crescolabs.com" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> info@crescolabs.com </a> </p>
</div>
<p>News Provided by Business Wire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
March 04 | 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
</div>
<p> The presentation will be conducted by live webcast, and will be accessible through the company’s website at <a href="https://c212.net/c/link/?t=0&l=en&o=3085816-1&h=876494789&u=https%3A%2F%2Fwww.canopygrowth.com%2Finvestors%2Finvestor-events%2F&a=https%3A%2F%2Fwww.canopygrowth.com%2Finvestors%2Finvestor-events%2F" rel="nofollow noopener noreferrer" target="_blank"> https://www.canopygrowth.com/investors/investor-events/ </a> . A replay option will be available on the company’s website until <span> September 7, 2021 </span> for those that cannot participate in the live event. </p>
<p> <b> About Canopy Growth Corporation <br/></b> Canopy Growth (TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both <span> Canada </span> and <span> Germany </span> . Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including <span> Canada </span> , <span> the United States </span> , and <span> Europe </span> through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional federally-permissible CBD products to <span> the United States </span> through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit <a href="https://c212.net/c/link/?t=0&l=en&o=3085816-1&h=3510474729&u=http%3A%2F%2Fwww.canopygrowth.com%2F&a=www.canopygrowth.com" rel="nofollow noopener noreferrer" target="_blank"> www.canopygrowth.com </a> . </p>
<p> <b> Notice Regarding Forward Looking Statements <br/></b> This press release contains “forward-looking statements” and “forward-looking information” within the meaning of applicable U.S. and Canadian securities laws (collectively, “forward-looking statements”), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use </p>
<p> of such terms and phrases as “intend,” “goal,” “strategy,” “estimate,” “expect,” “project,” “projections,” “forecasts,” “plans,” “seeks,” “anticipates,” “potential,” “proposed,” “will,” “should,” “could,” “would,” “may,” “likely,” “designed to,” “foreseeable future,” “believe,” “scheduled” and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward–looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward–looking statements and the forward–looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation (“Canopy”) can be found under the section entitled “Risk Factors” in Canopy’s Annual Report on Form 10-K for the year ended March 31, 2020, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at <a href="https://c212.net/c/link/?t=0&l=en&o=3085816-1&h=2707441983&u=http%3A%2F%2Fwww.sec.gov%2Fedgar&a=www.sec.gov%2Fedgar" rel="nofollow noopener noreferrer" target="_blank"> www.sec.gov/edgar </a> and <a href="https://c212.net/c/link/?t=0&l=en&o=3085816-1&h=762893464&u=http%3A%2F%2Fwww.sedar.com%2F&a=www.sedar.com" rel="nofollow noopener noreferrer" target="_blank"> www.sedar.com </a> , respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward–looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward– looking statement. Readers are cautioned not to put undue reliance on any forward–looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. </p>
<div id="DivAssetPlaceHolder2"> </div>
<p id="PURL"> <img alt="Cision" class="lazy" data-src="https://c212.net/c/img/favicon.png?sn=OT98190&sd=2021-03-04" data-srcset="" height="12" src="https://c212.net/c/img/favicon.png?sn=OT98190&sd=2021-03-04" srcset="" title="Cision" width="12"/> View original content to download multimedia: <a href="http://www.prnewswire.com/news-releases/canopy-growth-to-participate-in-bofa-securities-virtual-consumer--retail-technology-conference-on-march-11-2021-301240144.html" id="PRNURL" rel="nofollow noopener noreferrer" target="_blank"> http://www.prnewswire.com/news-releases/canopy-growth-to-participate-in-bofa-securities-virtual-consumer–retail-technology-conference-on-march-11-2021-301240144.html </a> </p>
<p> SOURCE Canopy Growth Corporation </p>
<p> <img alt="" class="lazy" data-src="https://rt.newswire.ca/rt.gif?NewsItemId=C2338&Transmission_Id=202103040730CANADANWCANADAPR_C2338&DateId=20210304" data-srcset="" src="https://rt.newswire.ca/rt.gif?NewsItemId=C2338&Transmission_Id=202103040730CANADANWCANADAPR_C2338&DateId=20210304" srcset=""/></p>
<p> <img alt="Cision" class="lazy" data-src="https://c212.net/c/img/favicon.png?sn=C2338&sd=2021-03-04" data-srcset="" height="12" src="https://c212.net/c/img/favicon.png?sn=C2338&sd=2021-03-04" srcset="" title="Cision" width="12"/> View original content to download multimedia: <a href="http://www.newswire.ca/en/releases/archive/March2021/04/c2338.html" rel="noopener noreferrer" target="_blank"> http://www.newswire.ca/en/releases/archive/March2021/04/c2338.html </a> </p>
</div>
</div>
<p>News Provided by Canada Newswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less